Inspire Advisors, LLC Apellis Pharmaceuticals, Inc. Transaction History

Inspire Advisors, LLC

  • $737 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023
SELL
$23.65 - $89.22 $149,988 - $565,833
-6,342 Reduced 50.91%
6,115 $232,000
Q2 2023

Jul 31, 2023
BUY
$76.68 - $93.31 $23,464 - $28,552
306 Added 2.52%
12,457 $1.13 Million
Q1 2023

Apr 24, 2023
BUY
$46.59 - $66.96 $566,115 - $813,630
12,151 New
12,151 $801,000

Others Institutions Holding APLS

# of Institutions
302
Shares Held
112M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.19B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Inspire Advisors, LLC Portfolio

Follow Inspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email